Active Ingredient History

  • Now
Lirilumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3.   Wikipedia

More Chemistry
anti-kir antibody | bms-986015 | bms-986015-01 | iph2102 | lirilumab


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue